HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: Incidence and clinical outcome in 31 cases

Transfusion

Volumn 44, Issue 6, 2004, Pages 844-848

  Rousseau, Julie ^a   Goldman, Mindy ^b   David, Michèle ^b  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; HUMAN PLATELET ANTIGEN 5B; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG; 5B ALLOANTIGEN, HUMAN; ALLOANTIBODY; IMMUNOGLOBULIN;

ADULT; ALLOIMMUNITY; ARTICLE; CANADA; CLINICAL FEATURE; FEMALE; GENE FREQUENCY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NEWBORN ALLOIMMUNE THROMBOCYTOPENIA; OUTCOMES RESEARCH; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; CYTOLOGY; FETUS BLOOD; GENETICS; IMMUNOLOGY; MALE; NEWBORN; NEWBORN SCREENING; PASSIVE IMMUNIZATION; PREGNANCY; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW;

ADULT; ANTIGENS, HUMAN PLATELET; FEMALE; FETAL BLOOD; GENE FREQUENCY; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; ISOANTIBODIES; MALE; NEONATAL SCREENING; PREGNANCY; QUEBEC; RECURRENCE; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 2942529069     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2004.03304.x     Document Type: Article

References (37)

1. Harrington WJ, Sprague CC, Minnich V, et al. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med 1953;38:433.
2. Shulman NR, Marder VJ, Hiller MC, Collier EM. Platelet and leucocyte iso-antigens and their antibodies: serologic, physiologic and clinical studies. In: Moore CV, Brown EB, editors. Progress in hematology. No. 4. New York: Grune & Stratton; 1964:222.
3. Mueller-Eckhardt C, Kiefel V, Grubert A, et al. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989;1:363-6.
4. Davoren A, McParland P, Crowley J, et al. Antenatal screening for human platelet antigen-1a: results of a prospective study at a large maternity hospital in Ireland. Br J Obstet Gynaecol 2003;110:492-6.
5. Durand-Zaleski I, Schlegel N, Blum-Boisgard C, et al. Screening primiparous women and newborns for fetal/neonatal alloimmune thrombocytopenia: a prospective comparison of effectiveness and costs. Am J Perinatol 1996;13:423-31.
6. Panzer S, Auerbach L, Cechova E, et al. Maternal alloimmunization against fetal platelet antigens: a prospective study. Br J Haematol 1995;90:655-60.
7. Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: a prospective study. Blood 1997;89:4402-6.
8. Doughty HA, Murphy MF, Metcalfe P, Waters AH. Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study. Br J Haematol 1995;90:321-5.
9. Santoso S, Kiefel V. Human platelet-specific alloantigens: update. Vox Sang 1998;74(Suppl 2):249-53.
10. Smith J, Kelton JG, Horsewood P, et al. Platelet specific alloantigens on the platelet glycoproteine Ia/IIa complex. Br J Haematol 1989;72:534-8.
11. a: report of 4 cases with neonatal alloimmune thrombocytopenia. Vox Sang 1988;54:101-6.
12. b alloantigen system on human platelets. Blood 1989;73:2219-23.
13. b are associated with a single amino acid polymorphism on glycoprotein 1a (integrin subunit alpha 2). J Clin Invest 1993;92:2427-32.
14. Pischel KD, Bluestein HG, Woods VL Jr. Platelet glycoprotein Ia, Ic, and IIa are physicochemically indistinguishable from the very late activation antigens adhesion-related proteins of lymphocytes and other cell types. J Clin Invest 1988;81:505-13.
15. b. Br J Haematol 1989;72:191-8.
16. a. Vox Sang 1989;57:90-1.
17. A1 antigen. Hum Immunol 1990;27:73-9.
18. Semana G, Zazoun T, Alizadeh M, et al. Genetic susceptibility and anti-human platelet antigen 5b alloimmunization role of HLA class II and TAP genes. Hum Immunol 1996;46:114-9.
19. Décary F, L'Abbé D, Tremblay L, Chartrand P. The immune response to the HPA-1a antigen: association with HLA-DRw52a. Transfus Med 1991;1:55-62.
20. Ulm B, Ulm MR, Deutinger J, et al. Spontaneous rise of fetal platelet counts despite increasing anti-HPA-5b antibodies. Vox Sang 1997;72:111-3.
21. Kurz M, Stockelle E, Eichelberger B, Panzer S. IgG titer, subclass, and light-chain phenotype of pregnancy-induced HPA-5b antibodies that cause or do not cause neonatal alloimmune thrombocytopenia. Transfusion 1999;39:379-82.
22. a) neonatal alloimmune thrombocytopenia: clinical and immunological analysis of 39 cases. Br J Haematol 1991;78:425-9.
23. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987;70:1722-6.
24. Cavanagh G, Dunn AN, Chapman CE, Metcalfe P. HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations. Transfus Med 1997;7:41-5.
25. Skogen B, Bellissimo DB, Hessner MJ, et al. Rapid determination of platelet alloantigen genotypes by polymerase chain reaction using allele-specific primers. Transfusion 1994;34:955-60.
26. Hou M, Rosengren-Kogan L, Forsgerg B, et al. Genotyping of the platelet-specific alloantigen HPA-5 (Br (a) /Br (b) using polymerase chain reaction with sequences specific primers (PCR-SSP). Eur J Haematol 1996;57:208-13.
27. Goldman M, Trudel E, Richard L. Report on the Eleventh International Society of Blood Transfusion Platelet Genotyping and Serology Workshop. Vox Sang 2003;85:149-55.
28. Kim HO, Jin Y, Kickler TS, et al. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 1995;35:863-7.
29. Ohto H, Yamaguchi T, Takeuchi C, et al. Anti-HPA-5b-induced neonatal alloimmune thrombocytopenia: antibody titre as a predictor. Br J Haematol 2000;110:223-7.
30. a) as determined by antenatal screening. Blood 1998;92:2280-7.
31. Davoren A, McParland P, Barnes CA, Murphy WG. Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases. J Clin Pathol 2002;55:289-92.
32. McFarland J, Curtis BR, Friedman KD, et al. Incompatibilities implicated in 975 cases of suspected neonatal alloimmune thrombocytopenia (NAITP) (abstract). Blood 2001;98:1882.
33. Murphy MF, Williamson LM, Urbaniak SJ. Antenatal screening for fetomaternal alloimmune thrombocytopenia: should we be doing it? Vox Sang 2002;83 (Suppl. 1):409-16.
34. Dawkins B. Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test. Vox Sang 1995;68:27-34.
35. Proulx C, Filion M, Goldman M, et al. Analysis of immunoglobulin class, IgG subclass and titre of HPA-1a antibodies in alloimmunized mothers giving birth to babies with and without neonatal alloimmune thrombocytopenia. Br J Haematol 1994;87:813-7.
36. McFarland JG, Frenzke M, Aster RH. Testing of maternal sera in pregnancies at risk for neonatal alloimmune thrombocytopenia. Transfusion 1989;29:128-33.
37. Paidas MJ, Berkowitz RL, Lynch L, et al. Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. Am J Obstet Gynecol 1995;172:475-9.